Major deals, including Johnson & Johnson’s $14.6B Intra-Cellular acquisition, signal renewed dealmaking, supported by nearly ...

Several members of our firm’s life sciences team were on the ground at the 43rd Annual J.P. Morgan Healthcare Conference in ...

Morgan Health launched a few months after J.P. Morgan, Amazon and Berkshire Hathaway disbanded their Haven joint venture.

A tide change is rippling across healthcare. As industry leaders converged on San Francisco for the 2025 JP Morgan Healthcare conference, they echoed optimism about a renewed stability in healthcare, ...

Surgery centers are the next focus, President and CEO Martin Bonick told a recent industry conference. But that push is more ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

A major conference that took place earlier this month is set to return to San Francisco next year, according to SF Mayor Daniel Lurie’s office. The J.P. Morgan ...

The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new ...

In this conversation, the Business Journal invites Cadrenal Founder & CEO Quang Pham to talk about the biopharmaceutical ...

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties following the fatal shooting of UnitedHealthcare’s CEO in December.